Visualisation of doxorubicin in human and animal tissues and in cell cultures by immunogold-silver staining.

por Henneberry, H. P., Aherne, G. W.
Publicado 1992

Development and application of a radioimmunoassay for methotrexate.

por Aherne, G. W., Piall, E. M., Marks, V.
Publicado 1977

A radioimmunoassay for cytosine arabinoside.

por Piall, E. M., Aherne, G. W., Marks, V. M.
Publicado 1979

Selective potentiation of lometrexol growth inhibition by dipyridamole through cell-specific inhibition of hypoxanthine salvage.

por Turner, R. N., Aherne, G. W., Curtin, N. J.
Publicado 1997

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition

por Webley, S D, Welsh, S J, Jackman, A L, Aherne, G W
Publicado 2001

Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy.

por Findlay, M. P., Cunningham, D., Morgan, G., Clinton, S., Hardcastle, A., Aherne, G. W.
Publicado 1997

Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitorD9331

por Webley, S D, Hardcastle, A, Ladner, R D, Jackman, A L, Aherne, G W
Publicado 2000

The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice.

por Walton, M. I., Mitchell, F., Aherne, G. W., Medlow, C. J., Boyle, F. T., Jackman, A. L.
Publicado 1998

Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines.

por Jackman, A. L., Kelland, L. R., Kimbell, R., Brown, M., Gibson, W., Aherne, G. W., Hardcastle, A., Boyle, F. T.
Publicado 1995

Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical models.

por Aherne, G. W., Ward, E., Lawrence, N., Dobinson, D., Clarke, S. J., Musgrove, H., Sutcliffe, F., Stephens, T., Jackman, A. L.
Publicado 1998

Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma

por Ford, H E R, Cunningham, D, Ross, P J, Rao, S, Aherne, G W, Benepal, T S, Price, T, Massey, A, Vernillet, L
Publicado 2000